- Report
- November 2022
- 54 Pages
Global
- Report
- November 2022
- 117 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- March 2022
- 61 Pages
Global
- Report
- February 2022
- 47 Pages
Global
- Report
- January 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- June 2018
- 70 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- January 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- January 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- January 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- January 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- November 2023
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- May 2023
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- April 2023
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- April 2023
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- March 2024
- 135 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- November 2021
- 120 Pages
Global
From €2275EUR$2,500USD£1,951GBP
- Report
- February 2021
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- June 2021
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- February 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- May 2022
- 38 Pages
Global
From €1820EUR$2,000USD£1,560GBP

The Drug Discovery market is a sector of the pharmaceutical industry that focuses on the research and development of new drugs. It involves the identification of potential drug targets, the synthesis of new compounds, and the testing of these compounds for efficacy and safety. Companies in this market use a variety of techniques, such as high-throughput screening, computer-aided drug design, and molecular modeling, to identify and develop new drugs.
The Drug Discovery market is highly competitive, with many large pharmaceutical companies and biotechnology firms competing for market share. Some of the major players in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, AstraZeneca, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more